Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yurong Lai

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Nanoscale Research Letters|July 3, 2010
Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug DeliveryPo-Chang Chiang, Jason W Alsup, Yurong Lai, et al.
American Journal of Physiology. Cell Physiology|October 1, 2004
Conserved residues F316 and G476 in the concentrative nucleoside transporter 1 (hCNT1) affect guanosine sensitivity and membrane expression, respectivelyYurong Lai, Eun-Woo Lee, Carl C Ton, et al.
Clinical Pharmacology and Therapeutics|December 16, 2017
Gaining Mechanistic Insight Into Coproporphyrin I as Endogenous Biomarker for OATP1B-Mediated Drug-Drug Interactions Using Population Pharmacokinetic Modeling and SimulationShelby Barnett, Kayode Ogungbenro, Karelle Ménochet, et al.
Pharmaceutical Research|May 29, 2012
Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactionsManthena V S Varma, Yurong Lai, Bo Feng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 28, 2019
Induction of Human Intestinal and Hepatic Organic Anion Transporting Polypeptides: Where Is the Evidence for Its Relevance in Drug-Drug Interactions?A David Rodrigues, Yurong Lai, Hong Shen, et al.
Frontiers in Pharmacology|August 6, 2019
Lysosomal P-gp-MDR1 Confers Drug Resistance of Brentuximab Vedotin and Its Cytotoxic Payload Monomethyl Auristatin E in Tumor CellsPeggy Liu-Kreyche, Hong Shen, Anthony M Marino, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 5, 2019
Organic Anion-Transporting Polypeptide Genes Are Not Induced by the Pregnane X Receptor Activator Rifampin: Studies in Hepatocytes In Vitro and in Monkeys In VivoCongrong Niu, Yujin Wang, Xiaofeng Zhao, et al.
Drug Metabolism Letters|August 27, 2010
Two branched polar groups and polar linker moieties of thiophene amide derivatives are essential for MRP2/ABCC2 recognitionYiding Hu, Kathleen E Sampson, Li Xing, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 5, 2016
Mechanistic Modeling of Pitavastatin Disposition in Sandwich-Cultured Human Hepatocytes: A Proteomics-Informed Bottom-Up ApproachAnna Vildhede, André Mateus, Elin K Khan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 12, 2013
Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pumpA David Rodrigues, Yurong Lai, Mary Ellen Cvijic, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Nanoscale Research Letters|July 3, 2010
Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug DeliveryPo-Chang Chiang, Jason W Alsup, Yurong Lai, et al.
American Journal of Physiology. Cell Physiology|October 1, 2004
Conserved residues F316 and G476 in the concentrative nucleoside transporter 1 (hCNT1) affect guanosine sensitivity and membrane expression, respectivelyYurong Lai, Eun-Woo Lee, Carl C Ton, et al.
Clinical Pharmacology and Therapeutics|December 16, 2017
Gaining Mechanistic Insight Into Coproporphyrin I as Endogenous Biomarker for OATP1B-Mediated Drug-Drug Interactions Using Population Pharmacokinetic Modeling and SimulationShelby Barnett, Kayode Ogungbenro, Karelle Ménochet, et al.
Pharmaceutical Research|May 29, 2012
Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactionsManthena V S Varma, Yurong Lai, Bo Feng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 28, 2019
Induction of Human Intestinal and Hepatic Organic Anion Transporting Polypeptides: Where Is the Evidence for Its Relevance in Drug-Drug Interactions?A David Rodrigues, Yurong Lai, Hong Shen, et al.
Frontiers in Pharmacology|August 6, 2019
Lysosomal P-gp-MDR1 Confers Drug Resistance of Brentuximab Vedotin and Its Cytotoxic Payload Monomethyl Auristatin E in Tumor CellsPeggy Liu-Kreyche, Hong Shen, Anthony M Marino, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 5, 2019
Organic Anion-Transporting Polypeptide Genes Are Not Induced by the Pregnane X Receptor Activator Rifampin: Studies in Hepatocytes In Vitro and in Monkeys In VivoCongrong Niu, Yujin Wang, Xiaofeng Zhao, et al.
Drug Metabolism Letters|August 27, 2010
Two branched polar groups and polar linker moieties of thiophene amide derivatives are essential for MRP2/ABCC2 recognitionYiding Hu, Kathleen E Sampson, Li Xing, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 5, 2016
Mechanistic Modeling of Pitavastatin Disposition in Sandwich-Cultured Human Hepatocytes: A Proteomics-Informed Bottom-Up ApproachAnna Vildhede, André Mateus, Elin K Khan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 12, 2013
Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pumpA David Rodrigues, Yurong Lai, Mary Ellen Cvijic, et al.
Pageof 14